These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12420156)

  • 21. Effects of ritanserin on aversive classical conditioning in humans.
    Hensman R; Guimarães FS; Wang M; Deakin JF
    Psychopharmacology (Berl); 1991; 104(2):220-4. PubMed ID: 1908584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buspirone induced acute and chronic changes of neural activation in the periaqueductal gray of rats.
    Lim LW; Temel Y; Sesia T; Vlamings R; Visser-Vandewalle V; Steinbusch HW; Blokland A
    Neuroscience; 2008 Jul; 155(1):164-73. PubMed ID: 18588948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.
    Eskow KL; Gupta V; Alam S; Park JY; Bishop C
    Pharmacol Biochem Behav; 2007; 87(3):306-14. PubMed ID: 17553556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.
    Piskulić D; Olver JS; Maruff P; Norman TR
    Hum Psychopharmacol; 2009 Aug; 24(6):437-46. PubMed ID: 19637398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
    Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of the anxiolytic effects of buspirone in high- and low-anxious normal humans assessed by frontal midline theta activity.
    Mizuki Y; Suetsugi M; Ushijima I; Yamada M
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):291-300. PubMed ID: 7519702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT-1A receptor responsiveness following subchronic administration of buspirone.
    Khan A; Haleem DJ
    Pak J Pharm Sci; 2006 Oct; 19(4):333-7. PubMed ID: 17105715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aversive Pavlovian conditioning in childhood anxiety disorders: impaired response inhibition and resistance to extinction.
    Waters AM; Henry J; Neumann DL
    J Abnorm Psychol; 2009 May; 118(2):311-21. PubMed ID: 19413406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of buspirone on aggressive and anxiety behavior of male mice with various aggressive experience].
    Bondar' NP; Kudriavtseva NN
    Eksp Klin Farmakol; 2003; 66(4):12-6. PubMed ID: 14558344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cytochrome P450 (CYP) 3A4 inhibitors on the anxiolytic action of tandospirone in rat contextual conditioned fear.
    Nishikawa H; Inoue T; Masui T; Izumi T; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):926-31. PubMed ID: 17376576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opposite effects of nefazodone in two human models of anxiety.
    Silva M; Hetem LA; Guimarães FS; Graeff FG
    Psychopharmacology (Berl); 2001 Aug; 156(4):454-60. PubMed ID: 11498723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buspirone attenuates conditioned fear-induced c-Fos expression in the rat hippocampus.
    Wisłowska-Stanek A; Zienowicz M; Lehner M; Taracha E; Bidziński A; Maciejak P; Skórzewska A; Szyndler J; Płaźnik A
    Neurosci Lett; 2005 Dec; 389(2):115-20. PubMed ID: 16095819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation.
    Menon M; Jensen J; Vitcu I; Graff-Guerrero A; Crawley A; Smith MA; Kapur S
    Biol Psychiatry; 2007 Oct; 62(7):765-72. PubMed ID: 17224134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques.
    Fontenot MB; Padgett EE; Dupuy AM; Lynch CR; De Petrillo PB; Higley JD
    Comp Med; 2005 Feb; 55(1):67-74. PubMed ID: 15766212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of benzodiazepine and serotonergic mechanisms in conditioned freezing and antinociception using electrical stimulation of the dorsal periaqueductal gray as unconditioned stimulus in rats.
    Castilho VM; Macedo CE; Brandão ML
    Psychopharmacology (Berl); 2002 Dec; 165(1):77-85. PubMed ID: 12474121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of the novel anxiolytic drug lesopitron, a full and selective 5-HT1A receptor agonist, on pupil diameter and oral temperature in man: comparison with buspirone.
    Phillips MA; Szabadi E; Bradshaw CM
    J Psychopharmacol; 1999 Dec; 13(4):391-7. PubMed ID: 10667616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lateral amygdala processes the value of conditioned and unconditioned aversive stimuli.
    Blair HT; Sotres-Bayon F; Moita MA; Ledoux JE
    Neuroscience; 2005; 133(2):561-9. PubMed ID: 15878802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats.
    Zuideveld KP; Rusiç-Pavletiç J; Maas HJ; Peletier LA; Van der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1130-7. PubMed ID: 12438536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Context and renewal of conditioned fear: an experimental evaluation using 20% carbon dioxide-enriched air as an unconditioned stimulus.
    Finlay CG; Forsyth JP
    J Anxiety Disord; 2009 Aug; 23(6):737-45. PubMed ID: 19342193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.